CVR 40831622Public limited company (A/S)Fremstilling af farmaceutiske præparater (212000)BallerupFounded 23 Sep 2019
Employees
2
CVR registry, Aug 2026
+1 (+100%) over 12 months
Gross profit
49.2M
DKK, annual report 2025
-16.9% on 2024
Result
+131.7M
DKK, annual report 2025
Equity
163.8M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about BioNordic A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexStefan Bødtker Michelsen25% to under 33.3% of capital and votes, since 1 Mar 2022
Nicolas Bødtker Nielsen25% to under 33.3% of capital and votes, since 1 Mar 2022
and 4 moreTroels Zakarias Glahn Kristiansensince 1 Jan 2026
10% to under 15% of capital and votessince 23 Sep 2019
25% to under 33.3% of capital and votessince 1 Mar 2022
25% to under 33.3% of capital and votessince 1 Mar 2022
25% to under 33.3% of capital and votessince 1 Mar 2022
10% to under 15% of capital and votessince 1 Mar 2022
5% to under 10% of capital and votessince 1 Mar 2022
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
10% to under 15% of capital and votes1 Mar 2022 to 1 Nov 2023
1 Danish company.
CVR 4337292020% to under 25% of capital and votes
Found by searching the CVR owner register (ejerregister) for BioNordic A/S as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 40746471100% of capital and votes1 Jan 2020 to 9 Dec 2024
CVR records founders at incorporation. It does not record whether they are alive or still involved.
23 Sep 2019 to 1 Nov 2026.
23 Sep 2019 to 1 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 40,332 | 77,810 | 95,559 | 59,212 | 49,189 |
| Operating profit | -6,725 | +19,027 | +43,562 | +13,114 | +12,446 |
| Result for the year | +408 | +5,157 | +24,549 | -20,860 | +131,702 |
| Equity | 18,211 | 24,828 | 48,871 | 31,025 | 163,782 |
| Total assets | 252,629 | 394,101 | 413,922 | 394,857 | 239,170 |
| Employees (average) | 84 | 98 | 83 | 77 | 62 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | 92.9% | 22.8% | -38% | -16.9% |
| EBITDA | 14,846 | 28,588 | 56,930 | 24,213 | 18,512 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 36.8% | 36.7% | 59.6% | 40.9% | 37.6% |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 16.7% | -15.3% | -7.2% | -19.5% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 18,734 | 7,473 | 7,145 | 2,580 | 15,790 |
| Gearing, NIBD / EBITDA | 1.3x | 0.3x | 0.1x | 0.1x | 0.9x |
| ROIC (afkast af investeret kapital) | -13.1%note 2 | 42.9%note 2 | 71.4% | 22.8%note 3 | 9.1%note 2 |
| Capex (investeringer i anlægsaktiver) | 8,250 | 38,124 | 15,224 | 8,697 | 20,541 |
| FCFF / EBITDA (pengestrømskonvertering) | 37.1%note 4 | -30.8%note 4 | -97.2%note 5 | 106.2%note 6 | -276.5%note 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 115,665 | 124,249 | 188,969 | 182,238 | 15,790 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 1 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 1 Jul 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 17 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 10 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 20 Jul 2022
BioNordic A/S has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 29 Jan 2027.
BioNordic A/S has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 30 Dec 2026.
1 registered in CVR.
P-number 1025094545Borupvang 3, 2750 Ballerup
No other current company drawn.
No other current company drawn.